Avenue Therapeutics, Inc.
ATXI
$0.26
-$0.02-8.20%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.94M | 2.42M | 2.86M | 3.71M | 3.33M |
| Total Receivables | -- | -- | -- | -- | 800.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 34.00K | 51.00K | 76.00K | 16.00K | 35.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.98M | 2.47M | 2.93M | 3.73M | 4.16M |
|
|
|||||
| Total Current Assets | 1.98M | 2.47M | 2.93M | 3.73M | 4.16M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.98M | 2.47M | 2.93M | 3.73M | 4.16M |
|
|
|||||
| Total Accounts Payable | 999.00K | 854.00K | 724.00K | 1.03M | 456.00K |
| Total Accrued Expenses | 408.00K | 416.00K | 374.00K | 389.00K | 873.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 1.00K | 2.00K | -- |
| Total Other Current Liabilities | -- | -- | 1.00K | 2.00K | -- |
| Total Current Liabilities | 1.41M | 1.27M | 1.10M | 1.42M | 1.33M |
|
|
|||||
| Total Current Liabilities | 1.41M | 1.27M | 1.10M | 1.42M | 1.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.41M | 1.27M | 1.10M | 1.42M | 1.33M |
|
|
|||||
| Common Stock & APIC | 107.44M | 107.38M | 107.32M | 108.34M | 108.16M |
| Retained Earnings | -106.87M | -106.18M | -105.49M | -104.78M | -104.10M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 569.00K | 1.20M | 1.83M | 3.56M | 4.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 569.00K | 1.20M | 1.83M | 3.56M | 4.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -1.25M | -1.23M |
| Total Equity | 569.00K | 1.20M | 1.83M | 2.30M | 2.83M |
|
|
|||||